Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Lipitor goes off patent today, but Pfizer may’ve queered pitch for clones, impacting Ranbaxy-led Indian pharma Indian pharma companies’ quest to make millions from the sale of copycat versions of blockbuster drugs may turn out to be a flop show as innovative companies raise defences to protect their turf. The …
Drug firm Strides Arcolab on Thursday said it has received approval from the US health regulator to market two generic cancer drugs in the American market. Onco Therapies Ltd, a unit of Strides Arcolab, has received approval from the US Food and Drug Administration (USFDA) for marketing injectable Carboplatin and …
GUWAHATI: The country’s North Eastern region is rich in medicinal plants, but indiscriminate and unscientific collection is forcing many of the species into the verge of extinction, say experts. This matter was raised in a recent seminar organised by the apex funding institution of the region, the North Eastern Development …
The commissioner of the Food and Drug Administration on Friday revoked the approval of the drug Avastin as a treatment for breast cancer, ruling on an emotional issue that pitted the hopes of some desperate patients against the statistics of clinical trials. The commissioner, Dr. Margaret A. Hamburg, said that …
The health ministry is planning to develop a foolproof mechanism to ensure recall of all faulty and banned drugs from the Rs 60,000-crore domestic pharmaceutical market. The move will strengthen the existing recall provisions under the Drugs and Cosmetic Rules. The current law, however, fails to prescribe time-bound recall formats. …
New Delhi: The Centre on Thursday responded to the Supreme Court’s concern over spiralling prices of essential medicines and promised to do all it could to put under a strict price control regime all 348 drugs included in the National List of Essential Medicines (NLEM), 2011. A bench comprising Justices …
India’s attempts to check foreign investment in pharma and expand drug pricing control could force multinationals to exit the country, the head of Pfizer India has warned. “India might not become attractive market if we have such controls, you will see companies pulling out of India,” Kewal Handa, the managing …
Even as India’s largest drug maker, Ranbaxy, is confident of launching its first “new drug” by January 2012 to combat malaria in the country, the global euphoria the potential drug had generated in the initial stages of its research seems missing. Health experts attribute this to the absence of international …
Aggressive marketing initiatives by Pfizer Inc may reduce Ranbaxy Laboratories’ earnings from the scheduled launch of its lowcost version of Lipitor, the world’s largest selling drug, in the US by the month end. The world’s largest drugmaker earns around $6 billion from Lipitor sales in the US and it has …
Foreign drugmakers fear they would be forced to cut prices of imported medicines by up to 90% A key clause in the government’s draft drug pricing policy has raised the hackles of foreign drugmakers who fear it could force them to sharply reduce prices of several imported medicines by up …
The country’s drug regulator has given conditional market approval for Ranbaxy Laboratories’ anti-malaria drug, paving the way for the launch of the country’s first privately-developed medicine and ending more than a decade of failures or near misses for India’s drug makers While the domestic drug industry has been successful in …
Govt plans to fix and regulate prices of all 348 essential drugs & their combinations The new pharmaceutical pricing policy proposed by the chemicals and fertilisers ministry last week will create distortions in the market and hamper the industry’s growth, some drugmakers and regulatory experts have claimed. Under the National …
Mumbai: There may be good newsfor consumerssoon.After yearsof dithering anddilly-dallying,the government proposes to bring all essential medicines under price control. The draft national pharmaceutical policy proposes to impose price control on the entire National List of EssentialMedicines—totalling 348 medicines. The essential list of medicines was revised recently by the government, …
Close to one lakh children below the age of five years died of diarrhoea attributable to rotavirus infection in 2008, accounting for 22 per cent of the total deaths reported globally, reports the latest edition of the Lancet Infection Diseases magazine. Diarrhoea related with the rotavirus infection resulted in 453,000 …
Preliminary results from the trial of a malaria vaccine show that it protected nearly half of the children who received it from bouts of serious malaria, scientists said Tuesday. The vaccine, known as RTS,S and made by GlaxoSmithKline, has been in development for more than 25 years, initially for the …
Drug maker Lupin has received final approval from the US health regulator to market a generic version of UCB’s Keppra Oral Solution, an anti-epilepsy drug, in the American market. The company’s subsidiary, Lupin Pharmaceuticals Inc, has received final approval for its Levetiracetam Oral Solution in the strength of 100mg/ml from …
Historic it may be—even if watered down. The unanimous adoption of a “political declaration” by the UN on the need to fight the rising tide of non-communicable diseases (NCD) is a singular development and, as analysts have been reminding us, it is only the second time a health issue has …
Tiered pricing - the concept of selling drugs and vaccines in developing countries at prices systematically lower than in industrialized countries - has received widespread support from industry, policymakers, civil society, and academics as a way to improve access to medicines for the poor. We carried out case studies based …
Has To Reply In 4 Weeks On Making Essential Medicines Affordable To Poor New Delhi: The Supreme Court on Tuesday wanted to know how serious the Centre was in bringing essential medicines, used by poor patients to fight ailments like tuberculosis, diarrhoea, heart diseases and malaria, under ambit of price …
